Full dossier in preparation
Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.
Process with priority
Sign in free to move this company to the front.
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of ODENTA is 0.1% (very low). The 2024 annual accounts show equity of €338k and a net result of €248k. Equity is shrinking by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 38% of 382 sector peers (fiscal year 2024). The company has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 7 annual accounts.
Signals
2 signals · with evidenceConsistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 09-07-2025, 22 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 09-07-2025 | 22 d early | 2025-00256263 |
| 31-12-2023 | 31-07-2024 | 26-07-2024 | 5 d early | 2024-00298893 |
| 31-12-2022 | 31-07-2023 | 31-08-2023 | 31 d late | 2023-00411824 |
| 31-12-2021 | 31-07-2022 | 26-09-2022 | 57 d late | 2022-20438916 |
| 31-12-2020 | 31-07-2021 | 31-08-2021 | 31 d late | 2021-66100226 |
| 31-12-2019 | 31-07-2020 | 12-10-2020 | 73 d late | 2020-61000459 |
| 31-12-2018 | 31-07-2019 | 29-08-2019 | 29 d late | 2019-58900319 |
| 31-12-2017 | 31-07-2018 | 23-08-2018 | 23 d late | 2018-48700119 |
| 31-12-2016 | 31-07-2017 | 14-08-2017 | 14 d late | 2017-43400498 |
| 31-12-2015 | 31-07-2016 | 07-09-2016 | 38 d late | 2016-59300260 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsLong-established
Founded in 1991, 35 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.1%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Long track record
−Multiple establishment units
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€248k-14.4%
Working capital€-334k-58.3%
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 09-07-2025 with the NBB · fiscal year 2024 · verkort
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Gross margin: growth of ~24.5%/year over 7 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 32.9% | 50.3% | |
| Net result | €248k | €72k | |
| Equity | €338k | €127k | |
| Gross operating margin | €725k | €179k | |
| Staff costs | €259k | €134k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P38
Stable position over 2020-2024
· n=93-382
P80
Improving position over 2020-2024
· n=91-372
P69
Improving position over 2020-2024
· n=93-382
P84
Improving position over 2020-2024
· n=89-372
Describes the position versus peers, not a forecast.
€463k
+3.5%
18-24
€248k
-14.4%
18-24
€386k
+10.8%
18-24
€1.03M
+14.3%
18-24
€338k
+208.3%
18-24
€-334k
-58.3%
18-24
4
+48.3%
18-24
€259k
+52.3%
18-24
€70k
-27.6%
18-24
€390k
+345.7%
18-24
€688k
-12.7%
18-24
€624k
-11.5%
18-24
€61k
-24.0%
18-24
0.47
-33.6%
18-24
0.45
-31.4%
18-24
32.9%
+169.9%
18-24
2.04
-71.7%
18-24
73.5%
-72.2%
18-24
24.2%
-25.0%
18-24
65.41
-69.8%
18-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €463k |
| Net profit | €248k |
| Cash flow | €386k |
| Staff costs | €259k |
| Income taxes | €70k |
| Dividends | - |
| Total assets | €1.03M |
| Equity | €338k |
| Debt | €688k |
| of which ≤ 1y | €624k |
| of which > 1y | €61k |
| Working capital | €-334k |
| Employees (FTE) | 4.3 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.47 |
| Quick ratio | 0.45 |
| Working capital ratio | -32.5% |
| Solvency | 32.9% |
| Debt / equity | 2.04 |
| Long-term debt ratio | 0.18 |
| Interest coverage | 65.41 |
| Gross margin | - |
| Net margin | - |
| ROA | 24.2% |
| ROE | 73.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.03M |
| Fixed assets | 21/28 | €736k |
| Tangible fixed assets | 22/27 | €736k |
| Current assets | 29/58 | €290k |
| Stocks & contracts in progress | 3 | €9k |
| Amounts receivable within one year | 40/41 | €13k |
| Investments | 50/53 | €248 |
| Cash & bank | 54/58 | €259k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.03M |
| Equity | 10/15 | €338k |
| Contributions / capital | 10/11 | €62k |
| Reserves | 13 | €25k |
| Accumulated profits (losses) | 14 | €251k |
| Amounts payable | 17/49 | €688k |
| Amounts payable after one year | 17 | €61k |
| Amounts payable within one year | 42/48 | €624k |
| Trade debts payable within one year | 44 | €141k |
| Income statement | ||
| Gross operating margin | 9900 | €725k |
| Operating result | 9901 | €325k |
| Financial income | 75 | €190 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €318k |
| Income taxes | 67/77 | €70k |
| Net result for the period | 9904 | €248k |
| Result to be appropriated | 9905 | €248k |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed53
/ 100
Fair
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Directors
Directors & mandates
6 directorsCurrent directors & mandates
-
Current19-12-2024 → present
Historic, not recently confirmed (1)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
Not recently confirmedlast confirmed in an act from 2016
Former directors (4)
-
Former28-02-2019 → 19-12-2024
3 events
- 19-12-2024 Resigned· Director
- 11-01-2024 Mandate renewed· Director
- 28-02-2019 Appointed· Director
-
Former28-02-2019 → 19-12-2024
3 events
- 19-12-2024 Resigned· Director
- 11-01-2024 Mandate renewed· Director
- 28-02-2019 Appointed· Director
-
Former28-02-2019 → 19-12-2024
3 events
- 19-12-2024 Resigned· Director
- 11-01-2024 Mandate renewed· Director
- 28-02-2019 Appointed· Director
-
Former28-02-2019 → 19-12-2024
6 events
- 19-12-2024 Resigned· Director
- 11-01-2024 Mandate renewed· Director
- 11-01-2024 Mandate renewed· Managing director
- 09-01-2024 Appointed· Managing director
- 28-02-2019 Appointed· Director
- 28-02-2019 Appointed· Managing director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
1 auditor| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| GRANT THORNTON BEDRIJFSREVISOREN - REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Nicolas Dumonceau |
- | 23-12-2024 → present |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Activiteiten van tandartspraktijken(86230) |
| Legal form | Public limited company(014) |
| Incorporation | 27-02-1991 |
| Status | Active |
| Postal code | 8930 |
Structure & network
Connections & network
4 connected companiesGroup structure
Sits on the board · 4 subsidiaries · 67 locations
Control→
Network connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control
1 partyControl over this companysits on this company's board1
4 subsidiaries · 67 locations
controls
ODENTABE 0443.478.852
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Locations & real estate
Registered office
on the map · from the address registerEstablishment units
2 locationsODENTA NV
since 19962.113.580.312
ODENTA
since 20242.358.105.434
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area1,301 m²
Buildings2
Building footprint527 m²
Volume (LiDAR)810 m³
Tallest building6.8 m · ±1 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34024A0225/00M000 | Flanders | 691 m² | 1 · 302 m² | - |
| 34032A0038/00S000 | Flanders | 610 m² | 1 · 225 m² | 6.8 m · 1 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
7 acts All acts · 7
updated 2 months ago
2026
04-06-2026 Board meeting · Merger · Accounting effect · Tax qualification
- Filing: 2026-06-02 · Dentius BV
- Publication: 2026-06-04 · Dentius BV
- Board meeting: 2026-06-01 · Dentius BV
- Merger: type: fusion_by_takeover, proposal_date: 2026-06-01 · Dentius BV
- Accounting effect: 2026-01-01 · ODENTA NV
- Tax qualification: tax_neutral · Dentius BV
- Power of attorney: date: 2026-06-01, scope: neerlegging en publicatie van het Fusievoorstel, representative: adriaan_de_leeuw · Dentius BV
- Power of attorney: date: 2026-06-01, scope: neerlegging en publicatie van het Fusievoorstel, representative: adriaan_de_leeuw · ODENTA NV
- Act object: HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN)
Summary:
Board meeting · Merger · Accounting effect · Tax qualification
04-06-2026 Board meeting · Merger · Accounting effect · Tax qualification
- Filing: 2026-06-02 · ODENTA
- Publication: 2026-06-04 · ODENTA
- Board meeting: 2026-06-01 · ODENTA
- Merger: type: fusion_by_takeover, direction: e1_to_e2, proposal_date: 2026-06-01 · ODENTA
- Accounting effect: 2026-01-01 · ODENTA
- Tax qualification: tax_neutral · ODENTA
- Power of attorney: date: 2026-06-01, scope: neerlegging en publicatie van het Fusievoorstel, representative: Adriaan de Leeuw · ODENTA
- Power of attorney: date: 2026-06-01, scope: neerlegging en publicatie van het Fusievoorstel, representative: Adriaan de Leeuw · Dentius BV
- Act object: HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN)
Summary:
Board meeting · Merger · Accounting effect · Tax qualification
2025
05-02-2025 Nicolas Dumonceau appointed as statutory auditor
29-01-2025 1 director appointed, 4 resigning
- Bjorn Borghs, Bestuurder
- Joanna Lenart, Bestuurder
- Inês Lopes Lago De Carvalho Marques, Bestuurder
- David Ponseele, Bestuurder
- Michel Ponseele, Bestuurder
Summary:
v3.2
2024
11-01-2024 5 reappointed
- PONSEELE Michel, Bestuurder
- PONSEELE David, Bestuurder
- LENART Joanna, Bestuurder
- LOPES LAGO DE CARVALHO MARQUES Inês, Bestuurder
- PONSEELE Michel, Gedelegeerd bestuurder
Summary:
v3.2
2019
24-04-2019 5 directors appointed
- Michel Ponseele, Bestuurder
- David Ponseele, Bestuurder
- Joanna Lenart, Bestuurder
- Inês Lopes Lago De Carvalho Marques, Bestuurder
- Michel Ponseele, Gedelegeerd bestuurder
Summary:
v3.2
2016
26-09-2016 3 reappointed
- Martine Vanryckeghem, Bestuurder
- Michel Ponseele, Bestuurder
- Michel Ponseele, Gedelegeerd bestuurder
Summary:
v3.2
Analysis
Snowflake analysis
financial profile on 5 axes74
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
53
Profitability
100
Solvency
41
Growth
78
Stability
100
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0775.927.843 · Brussel
BE 0773.716.540 · Antwerpen
BE 0803.221.366 · Torhout
BE 0785.426.816 · Sint-Jans-Molenbeek
BE 0760.384.681 · Gent
We hold annual accounts for 1,194 of the 6,937 companies in this sector. 959 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Tandartspraktijken85130Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
| Legal nameNL | ODENTA |
Registered office
Lauwestraat 114
8930 Menen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.